Amgen Inc. ranks in an above-average position in its peer group, with a broadly solid profile across the main structural dimensions.
Peer-relative scores, weakest to strongest
Amgen develops and markets biologic therapies and biosimilars, operating as a diversified player in the biopharmaceutical sector.
Amgen’s fundamentals show strong profitability with an operating margin of 35.5%, yet the stock trades at a forward P/E of 17.1x—over 40% below the peer median—reflecting investor caution despite growth and earnings power. As a diversified biopharma, Amgen generates robust blockbuster revenues and invests in AI-driven R&D, supporting its business model. The stock trades at a valuation discount despite operational strength. The market prices the stock with a discount relative to fundamentals.
Break down AMGN's position across all dimensions with the full interactive tool.
This analysis is rule-based and descriptive. Peer-relative scores are derived from functional peer group comparisons using publicly available financial data. Scores reflect structural positioning only and do not constitute investment advice, a buy or sell recommendation, or a forecast of future performance. AssetNext peer scores are recalculated periodically as new data becomes available.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.